[Membranous nephropathy]

Nihon Jinzo Gakkai Shi. 2010;52(7):894-8.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Autoantibodies
  • Complement Activation
  • Complement Membrane Attack Complex
  • Glomerulonephritis, Membranous* / classification
  • Glomerulonephritis, Membranous* / drug therapy
  • Glomerulonephritis, Membranous* / epidemiology
  • Glomerulonephritis, Membranous* / etiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Immunoglobulin G
  • Immunosuppressive Agents / administration & dosage
  • Neprilysin / immunology
  • Platelet Aggregation Inhibitors / administration & dosage
  • Prednisolone / administration & dosage
  • Prognosis
  • Receptors, Phospholipase A2 / immunology

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Autoantibodies
  • Complement Membrane Attack Complex
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Platelet Aggregation Inhibitors
  • Receptors, Phospholipase A2
  • Prednisolone
  • Neprilysin